why choose us

Clinical Trials Search

Showing 8,500 of 132,963 result(s)
The Effect of Progressive Relaxation Exercise and Sleep Hygiene Training on Sleep Quality and AnxietyLevel Given to Outpatients With Anxiety Disorder in Psychiatry Clinic

Status: Completed

Condition: Anxiety Disorder;Anxiety State

Interventions: Voluntary Consent Form, Personal Information Form, Pittsburgh Sleep Quality Index (PSQI), Sleep Hygiene Index (SHI) and Beck Anxiety Scale (BAS) will

Date: 2023-09-20

Comparing Two-Needle vs. Surgery-Guided Arthrocentesis for TMJ Disorders

Status: COMPLETED

Condition: Temporomandibular Joint Disorders

Interventions: Participants in this group will undergo arthrocentesis using the traditional two-needle technique.
The procedure involves the placement of one or

Date: 2023-09-20

Reducing Frailty for Older Cancer Survivors Using Supplements II

Status: NOT_YET_RECRUITING

Condition: Frailty

Interventions: 800mg Epigallocatechin-3-Gallate (EGCG)

Date: 2023-09-20

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Status: NOT_YET_RECRUITING

Condition: Uveal Melanoma

Interventions: An anti-cancer medication used to treat uveal melanoma.
Tebentafusp is a bispecific gp100 peptide-HLA-directed CD3 T cell engager.

Date: 2023-09-20

PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer

Status: Completed

Condition: Infertility, Female

Interventions: Participants are randomized to either another programmed FET Protocol vs. a modified natural FET protocol

Date: 2023-09-20

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

Status: Completed

Condition: Melanoma

Interventions: ABP 206 will be given intravenously over a period of 30 or 60 minutes, every 4 weeks (Q4W) for a total of 24 months.

Date: 2023-09-20

A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Processes in Healthy Adults

Status: ACTIVE_NOT_RECRUITING

Condition: Healthy Volunteers

Interventions: Infusion; intravenous

Date: 2023-09-20

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris

Status: COMPLETED

Condition: Acne Vulgaris

Interventions: The study medication will be self-applied topically, on the affected areas of the face lightly, once daily at bedtime, avoiding contact with the mouth

Date: 2023-09-20

Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom

Status: Completed

Condition: Sexually Transmitted Diseases

Interventions: 61mm width Synthetic Nitrile Condoms

Date: 2023-09-20